Application 079062
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | SOLUTION;ORAL | EQ 5MG BASE/5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 16571-769 | Escitalopram Oxalate | Escitalopram Oxalate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-769 | Escitalopram Oxalate | Escitalopram Oxalate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-769 | Escitalopram Oxalate | Escitalopram Oxalate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-769 | Escitalopram Oxalate | Escitalopram Oxalate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-769 | Escitalopram Oxalate | Escitalopram Oxalate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 57237-095 | Escitalopram Oxalate | Escitalopram Oxalate | Citron Pharma LLC | ANDA | Current |
| 65862-248 | Escitalopram Oxalate | Escitalopram Oxalate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-248 | Escitalopram Oxalate | Escitalopram Oxalate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-248 | Escitalopram Oxalate | Escitalopram Oxalate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-248 | Escitalopram Oxalate | Escitalopram Oxalate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-248 | Escitalopram Oxalate | Escitalopram Oxalate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-248 | Escitalopram Oxalate | Escitalopram Oxalate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-248 | Escitalopram Oxalate | Escitalopram Oxalate | Aurobindo Pharma Limited | ANDA | Current |